This Report Provides In-Depth Analysis of the Anastomosis Devices Market Report Prepared by P&S Intelligence, Segmented by Type (Biological, Synthetic), Application (Carotid Endarterectomy (CEA), Open Abdominal Aortic Aneurysm (AAA) Surgery, Vascular Bypass Surgery, Congenital Heart Disease), End User (Hospitals, Ambulatory Surgery Centers), and Geographical Outlook for the Period of 2019 to 2032
Explore the market potential with our data-driven report
Anastomosis Devices Market Analysis
The Anastomosis Devices Market revenue was USD 3312.9 million in 2024, and it is expected to witness a CAGR of 8.9% from 2025 to 2032, reaching USD 6480.3 million in 2032.
Patients are asking for more and more minimally invasive procedures that make use of highly advanced equipment to treat their medical conditions and shorten recovery times. Trans-catheters and drug-eluting stents are constantly being improved as a result, which will upsurge the adoption rate of anastomosis devices.
In addition, several companies, including Becton, CONMED Corporation, and Meril Life Sciences, are spending a lot of money on research and development (R&D) projects to create enhanced gadgets for better clinical outcomes. A positive picture for the sector is also being created by the expanding need for these appliances in other orthopedic, gynecological, and ophthalmology surgeries.
Myocardial infarction rates are predicted to rise, which will help the industry expand. In operations, the devices are crucial because chronic diseases are becoming more common, which will further boost the expansion of the market. Modern instruments can significantly reduce hazards that arise during surgical procedures. The benefits of using these gadgets, such as shorter operating times, greater surgeon convenience, reduced anesthetic exposure, and a lower chance of blood leakage, are driving their need. These instruments are also expected to be used by surgeons frequently if coronary bypass graft surgery (CABG) operations receive more funding.
Moreover, advantageous reimbursement scenarios in heart operations, such as open-heart valve replacement and angioplasty, in developed nations are likely to have a positive impact on the demand for such products.
Technological advancements, such as minimally invasive surgery devices, robotic-assisted surgery, AI and smart technologies, advanced staplers and suturing devices, 3D printing and customization, and integration with imaging technologies, are key market trend.
The integration of minimally invasive surgery and devices has eliminated the large incisions, longer recovery times, and increased risk of complication associated with the traditional open surgeries.
MISs, including robot-assisted surgeries, provides surgeons with greater control during delicate procedures.
Additionally, the integration of artificial intelligence helps surgeons with decision-making by analyzing real-time data, such as blood flow and pressure, which enhances the overall surgical procedure.
The integration of imaging technologies, such as high-definition cameras, ultrasound, and intraoperative imaging, has further advanced anastomosis procedures.
In September 2023, Stryker Corporation introduced the PROstep MIS Lapidus, an internal fixation system for treating bunions.
This system aims to address hallux valgus deformity through minimally invasive surgical reduction and the subsequent fusion of the first metatarsal cuneiform joint.
The system was presented at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Louisville.
Upsurge in Number of Operations Performed Globally Drives Market Growth
A surge in the number of operations performed globally is likely to fuel the growth of the industry.
This is because of the worldwide increase in the senior population and a rise in the prevalence of lifestyle diseases such as cancer, diabetes, hypertension, obesity, and heart illnesses.
Thus, the demand for anastomosis systems is expected to increase along with the rising number of these surgeries.
Also, these tools facilitate less scarring, quicker healing, and less blood loss.
In addition, surgeons perform techniques using extremely minimally invasive methods, and these instruments are particularly useful in treating cardiovascular conditions.
Thus, medical experts can operate safely and reliably even on the most-complicated parts of the heart, which will further encourage their adoption.
The use of these appliances further minimizes the need for a number of elements that can lead to suboptimal patient outcomes, such as induced hypothermic cardiac arrest, extracorporeal circulatory support, and aortic cross-clamping.
On top of that, they also aid in making the mechanics of the processes simpler for medical professionals.
Competition from Traditional Techniques Is Key Challenge in Market Growth
Traditional techniques, such as manual suturing, require minimal equipment in comparison to the advanced staplers, automated suturing devices, and robotic-assisted systems, which are now integrated with the anastomosis devices.
Most surgeons are more familiar, comfortable, and confident with the traditional techniques, due to which they are not moving toward advanced anastomosis.
Additionally, many healthcare facilities are facing challenges in transitioning from traditional open surgery to minimally invasive surgery, which is further restraining the market growth.
This is especially for the smaller hospitals in developing countries, which are not as well funded as large, investor-owned and government hospitals.
Anastomosis Devices Market Segmentation Analysis
Type Insights
Disposable category held the larger market share of 60%, in 2024, and it will grow at the higher CAGR during the forecast period. The dominance of the category is due to its property of eliminating the risk of cross-contamination, which is important for infection control and patient safety. Essentially, disposable anastomosis devices are witnessing a rapid growth due to the rising demand for high precision and minimal risk in surgeries.
Based on type, the market has the following categories:
Disposable (Larger and Faster-Growing Category)
Reusable
Product Type Insights
Staplers held the larger share, of 70%, in 2024, as they are used in multiple surgeries, such as the gastrointestinal, cardiovascular, and thoracic, in high volumes. Additionally, the growing popularity of minimally invasive surgeries is driving the demand for staplers for covering small incisions.
The sealants & adhesives category will grow at the highest CAGR during the forecast period. These agents are used in vascular and soft tissue surgeries as they are made from natural materials, such as fibrin and collagen, which promote natural tissue healing. Additionally, they provide a non-invasive, faster alternative to suturing and stapling with a reduced risk of contamination.
Based on product type, the market has the following categories:
Staplers (Largest Category)
Manual
Powered
Sutures
Absorbable
Synthetic
Natural
Non-absorbable
Automated suturing devices
Sealants & Adhesives (Fastest-Growing Category)
Biological
Synthetic
Application Analysis
Based on application, the cardiovascular and thoracic surgeries category accounted for the larger revenue share, over 75%, in 2024. This is because of the constant surge in the prevalence of CVDs, which are a key contributor to the rise in the number of heart surgeries. According to the WHO, there are approximately 17.9 million deaths occur due to CVDs. Almost 18 million people die of heart diseases a year, which reflects a massive demand for cardiac surgeries and other interventional procedures, such as catheterization and angiographies.
The gastrointestinal surgeries category is expected to experience substantial growth over the projected period due to the rising incidence of colorectal cancer and other gastrointestinal disorders that necessitate bowel resection. Since colorectal cancer is becoming more common in the APAC region, the market has a tremendous potential. Over the past 10 years, its incidence has increased two-to-four times in East Asian nations, such as Japan, China, South Korea, and Singapore.
Based on application, the market has the following categories:
Hospitals held the larger market share of 80%, in 2024, as they require anastomosis devices in massive volumes for cardiovascular and all other kinds of surgeries. Hospitals have a specialized department for complex surgeries, which are now demanding technologically advanced devices for anastomosis.
Ambulatory surgery centers and clinics will grow at the higher CAGR during the forecast period, due to the rising demand for cost-effective and quick surgeries with same-day discharge. Furthermore, the growing focus on healthcare efficiency and patient satisfaction is driving the demand for anastomosis devices in ambulatory surgery centers & clinics.
Based on end user, the market has the following categories:
Hospitals (Larger Category)
Ambulatory Surgery Centers & Clinics (Faster-Growing Category)
Drive strategic growth with comprehensive market analysis
North America accounted for the largest revenue share, around 40%, in 2024. Multiple cardiovascular indications, such as CAD and strokes, and gastric malignancies, such as adenocarcinoma and lymphoma, are becoming more prevalent in the region, which has led to an increase in procedures and a consequent rise in the need for anastomosis systems.
Moreover, according to the American Heart Association, approximately half of the people in the U.S. has a cardiovascular condition of some kind, such as cardiac disease and hypertension. Thus, these instruments for monitoring and diagnosing cardiovascular systems became necessary as heart diseases became more widespread. In addition, the growing elderly population with chronic illnesses and deskbound lifestyles is significantly contributing to the development of the regional market.
Furthermore, due to the rise in severe disorders brought on by the aging population, there is a corresponding rise in the demand for surgeries, which is responsible for the high usage of anastomosis devices in the region.
Europe is the second-largest market for anastomosis devices of the market revenue in 2024. The growth in the market is mainly attributable to the increasing aging population; rising prevalence of chronic diseases; presence of established players; and rapid number of product launches in the region.
Additionally, the European region has reported increasing number of hospitals and surgical centers where anastomosis devices are more common. A large number of hospitals are planned to be inaugurated in the upcoming years which are expected to increase various types of systems and anastomosis devices.
Companies in Germany, France, and the U.K. are actively involved in developing innovative and advanced products to cater the demand. Moreover, these nations also have well-developed healthcare infrastructure which are equipped with all large-to-small sized systems including anastomosis devices.
APAC region will grow at the highest CAGR during the forecast period. This rapid growth is due to the growing healthcare infrastructure in China, India, Japan, and South Korea. These countries have rapidly growing populations and a huge unmet need for quality healthcare due to the rising incidence of all kinds of chronic and acute health conditions.
Based on geography, the market has the following categories:
North America (Largest Regional Market)
U.S. (Larger Country Market)
Canada (Faster-Growing Country Market)
Europe
Germany (Largest Country Market)
U.K.
France
Italy (Fastest-Growing Country Market)
Spain
Asia-Pacific (Fastest-Growing Regional Market)
Japan
China (Largest Country Market)
India (Fastest-Growing Country Market)
South Korea
Australia
Latin America
Brazil (Larger Country Market)
Mexico (Faster-Growing Country Market)
Middle East and Africa
Saudi Arabia (Largest Country Market)
South Africa (Fastest-Growing Country Market)
U.A.E.
Anastomosis Devices Market Competitive Landscape
The market is fragmented due to the presence of a large number of players offering products such as staplers, sutures, sealants, and adhesives. The local market players in APAC and LATAM focus on the development of more-affordable and cost-effective options. The key market players are investing heavily in research & development, product innovation, and strategic partnership to gain dominance in the market. Several major companies are continuously investing in robotic systems, powered staplers, and automated suturing devices.
Key Anastomosis Devices Companies:
Medtronic plc
Johnson & Johnson
Stryker Corporation
B. Braun Melsungen AG
Covidien
Intuitive Surgical, Inc.
Terumo Corporation
Smith & Nephew plc
ConMed Corporation
Zimmer Biomet Holdings, Inc.
LeMaitre Vascular, Inc.
W.L. Gore & Associates, Inc.
Anastomosis Devices Market News
In March 2025, GT Metabolic Solutions Inc. expanded its MagDI system with the FDA clearence for its 50-mm magnet to replace 40-mm magnet. This expansion will help surgeons accommodate broader range of patients in magnet-assisted surgery for duodenal-ileal anastomosis.
In January 2025, Stryker Corporation announced the acquisition of Inari Medical Inc. for USD 4.9 billion in diluted equity, to enhance Stryker’s portfolio of peripheral vascular disease treatment solutions.
In January 2025, GI Windows Inc. received the FDA clearance for its FLEX SFM device magnetic compression anastomosis system in the U.S. The device will help in magnetic attraction for tissue compression and healing.
In May 2024, Ethicon, a subsidiary of Johnson & Johnson MedTech, launched the ECHELON LINEAR cutter, which is integrated with the 3D stapling technology and gripping surface technology (GST).
Want a report tailored exactly to your business need?
Leading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Client Testimonials
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Unmatched Standards
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
Complete Data Security
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws